 | • レポートコード：QYR9NV18079 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、潜在性結核感染（LTBI）検査の世界市場について調査・分析し、潜在性結核感染（LTBI）検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ツベルクリン皮膚試験（TST）、インターフェロンガンマ放出アッセイ（IGRA）、その他）、用途別（肺結核家者との家庭内接触、PLHIV、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の潜在性結核感染（LTBI）検査市場動向 ・主要企業別マーケットシェア ・潜在性結核感染（LTBI）検査の種類別市場規模2014-2019 （ツベルクリン皮膚試験（TST）、インターフェロンガンマ放出アッセイ（IGRA）、その他） ・潜在性結核感染（LTBI）検査の用途別市場規模2014-2019 （肺結核家者との家庭内接触、PLHIV、その他） ・潜在性結核感染（LTBI）検査の北米市場：主要企業・種類別/用途別市場規模 ・潜在性結核感染（LTBI）検査のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・潜在性結核感染（LTBI）検査の中国市場：主要企業・種類別/用途別市場規模 ・潜在性結核感染（LTBI）検査の日本国内市場：主要企業・種類別/用途別市場規模 ・潜在性結核感染（LTBI）検査の東南アジア市場：主要企業・種類別/用途別市場規模 ・潜在性結核感染（LTBI）検査のインド市場：主要企業・種類別/用途別市場規模 ・潜在性結核感染（LTBI）検査の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Qiagen、BioMerieux、Thermo Fisher Scientific、Danaher、Roche、Becton Dickinson、Agilent Technologies、Bio-Rad Laboratories、Eppendorf、Abbott Laboratories） ・潜在性結核感染（LTBI）検査の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.In 2018, the global Latent Tuberculosis Infection (LTBI) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories
Market segment by Type, the product can be split into
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Market segment by Application, split into
Household Contacts with Pulmonary TB
PLHIV
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Tuberculin Skin Test (TST)
1.4.3 Interferon Gamma Released Assay (IGRA)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2025)
1.5.2 Household Contacts with Pulmonary TB
1.5.3 PLHIV
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size
2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2019-2025)
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by by Players
3.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by by Players (2014-2019)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by by Players (2014-2019)
3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.2 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
3.3 Key Players Latent Tuberculosis Infection (LTBI) Testing Product/Solution/Service
3.4 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2014-2019)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2014-2019)
5 North America
5.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
5.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America
5.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
5.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
6 Europe
6.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe
6.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
7 China
7.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China
7.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
7.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
8 Japan
8.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan
8.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
8.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia
9.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
9.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
10 India
10.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India
10.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
10.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
11 Central & South America
11.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America
11.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
11.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
12 International Players Profiles
12.1 Qiagen
12.1.1 Qiagen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019))
12.1.5 Qiagen Recent Development
12.2 BioMerieux
12.2.1 BioMerieux Company Details
12.2.2 Company Description and Business Overview
12.2.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.2.4 BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.2.5 BioMerieux Recent Development
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.3.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.3.5 Thermo Fisher Scientific Recent Development
12.4 Danaher
12.4.1 Danaher Company Details
12.4.2 Company Description and Business Overview
12.4.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.4.4 Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.4.5 Danaher Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.5.4 Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Becton Dickinson
12.6.1 Becton Dickinson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.6.4 Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.6.5 Becton Dickinson Recent Development
12.7 Agilent Technologies
12.7.1 Agilent Technologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.7.4 Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.7.5 Agilent Technologies Recent Development
12.8 Bio-Rad Laboratories
12.8.1 Bio-Rad Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.8.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.8.5 Bio-Rad Laboratories Recent Development
12.9 Eppendorf
12.9.1 Eppendorf Company Details
12.9.2 Company Description and Business Overview
12.9.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.9.4 Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.9.5 Eppendorf Recent Development
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.10.4 Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.10.5 Abbott Laboratories Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Latent Tuberculosis Infection (LTBI) Testing Key Market Segments
Table Key Players Latent Tuberculosis Infection (LTBI) Testing Covered
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Tuberculin Skin Test (TST) Figures
Table Key Players of Tuberculin Skin Test (TST)
Figuer Interferon Gamma Released Assay (IGRA) Figures
Table Key Players of Interferon Gamma Released Assay (IGRA)
Figuer Others Figures
Table Key Players of Others
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2018 & 2025
Figure Household Contacts with Pulmonary TB Case Studies
Figure PLHIV Case Studies
Figure Others Case Studies
Figure Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions 2019-2025 (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions 2019-2025 (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions 2014-2019
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions 2014-2019
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue by by Players (2014-2019) (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Share by by Players (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by by Players in 2018
Table Global Latent Tuberculosis Infection (LTBI) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Latent Tuberculosis Infection (LTBI) Testing Product/Solution/Service
Table Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2014-2019) (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2014-2019) (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application in 2018
Figure North America Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table North America Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table North America Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table China Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table China Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Japan Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure India Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table India Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table India Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Table Qiagen Company Details
Table Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Qiagen Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure BioMerieux Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table BioMerieux Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Danaher Company Details
Table Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Danaher Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Danaher Recent Development
Table Roche Company Details
Table Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Roche Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Becton Dickinson Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Becton Dickinson Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Agilent Technologies Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table Eppendorf Company Details
Table Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Eppendorf Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Eppendorf Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Regions (2019-2025)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Regions in 2025
Figure North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Product (2019-2025)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Product in 2025
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2019-2025)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
潜在性結核感染（LTBI）検査のグローバル市場：規模・現状・予測2019-2025 Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to sti…- 潜在性結核感染（LTBI）検査のグローバル市場：規模・現状・予測2019-2025 Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to sti…
- 血流感染検査の世界市場予測 2023年：メーカー別、地域別、種類・用途別 BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections. Scope of the Report: This report studies the Blood Stream Infection Testing market status and outlook of Global and m…
- 院内尿路感染症検査のグローバル市場調査 2019年 The global Hospital-acquired Urinary Tract Infection Testing market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hospital-acquired Urinary Tract Infection Testing volume and value at global level, regio…
- 原油アッセイ試験のグローバル市場：規模・現状・予測2019-2025 A crude oil assay is essentially the chemical evaluation of crude oil feedstocks by petroleum testing laboratories. Each crude oil type has unique molecular, chemical characteristics. No crude oil type is identical and there are crucial differences in crude oil quality. The results of crude oil assa…